All Pharma News
Eli Lilly partner BioAge raises $170 mln for obesity treatment

Eli Lilly partner BioAge raises $170 mln for obesity treatment
REUTERS
13 Feb 2024
Share Share
GLP-1 enthusiasm pushes BioAge into new age with $170M series D

GLP-1 enthusiasm pushes BioAge into new age with $170M series D
Max Bayer FIERCE BIOTECH
13 Feb 2024
Share Share
BioAge Announces Plans for Phase 2 of BGE-105 Co-Administered With Tirzepatide

BioAge Announces Plans for Phase 2 of BGE-105 Co-Administered With Tirzepatide
BUSINESSWIRE
26 Oct 2023
Share Share
Lilly, BioAge to test muscle regeneration drug with tirzepatide

Lilly, BioAge to test muscle regeneration drug with tirzepatide
Annalee Armstrong FIERCE BIOTECH
26 Oct 2023
Share Share
BioAge Labs Appoints BJ Sullivan as Chief Strategy Officer

BioAge Labs Appoints BJ Sullivan as Chief Strategy Officer
BUSINESSWIRE
22 May 2023
Share Share
BioAge Labs to Present on Therapeutics for Brain Aging Targeting NLRP3, Apelin

BioAge Labs to Present on Therapeutics for Brain Aging Targeting NLRP3, Apelin
BUSINESSWIRE
26 Apr 2023
Share Share
BioAge Hosting Webcast to Discuss Phase 1b Data of BGE-105

BioAge Hosting Webcast to Discuss Phase 1b Data of BGE-105
BUSINESSWIRE
14 Dec 2022
Share Share
BioAge Labs reports positive data from muscle atrophy treatment trial

BioAge Labs reports positive data from muscle atrophy treatment trial
CLINICALTRIALSARENA
06 Dec 2022
Share Share
BioAge Announces Positive Topline Results for BGE-105 in Phase 1b Trial

BioAge Announces Positive Topline Results for BGE-105 in Phase 1b Trial
BUSINESSWIRE
05 Dec 2022
Share Share
BioAge Labs to Present Data on Novel Brain-Penetrant NLRP3 Inhibitors

BioAge Labs to Present Data on Novel Brain-Penetrant NLRP3 Inhibitors
BUSINESSWIRE
13 Oct 2022
Share Share